AlloVir Statistics
Share Statistics
AlloVir has 115.57M shares outstanding. The number of shares has increased by 1.31% in one year.
| Shares Outstanding | 115.57M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.31% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 51.78M |
| Failed to Deliver (FTD) Shares | 419 |
| FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 3.95M, so 3.42% of the outstanding shares have been sold short.
| Short Interest | 3.95M |
| Short % of Shares Out | 3.42% |
| Short % of Float | 7.65% |
| Short Ratio (days to cover) | 20.03 |
Valuation Ratios
The PE ratio is -0.37 and the forward PE ratio is -1.69.
| PE Ratio | -0.37 |
| Forward PE | -1.69 |
| PS Ratio | 0 |
| Forward PS | 19.9 |
| PB Ratio | 0.49 |
| P/FCF Ratio | -0.57 |
| PEG Ratio | n/a |
Enterprise Valuation
AlloVir Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 6.61, with a Debt / Equity ratio of 0.19.
| Current Ratio | 6.61 |
| Quick Ratio | 6.61 |
| Debt / Equity | 0.19 |
| Total Debt / Capitalization | 15.84 |
| Cash Flow / Debt | -4.54 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -1.31% and return on capital (ROIC) is -104.62%.
| Return on Equity (ROE) | -1.31% |
| Return on Assets (ROA) | -1% |
| Return on Capital (ROIC) | -104.62% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -23.80M |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -126.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -81.01% in the last 52 weeks. The beta is 0.74, so AlloVir 's price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | -81.01% |
| 50-Day Moving Average | 0.69 |
| 200-Day Moving Average | 0.75 |
| Relative Strength Index (RSI) | 31.71 |
| Average Volume (20 Days) | 342.30K |
Income Statement
In the last 12 months, AlloVir had revenue of $0 and earned -$190.42M in profits. Earnings per share was $-1.83.
| Revenue | 0 |
| Gross Profit | -398.00K |
| Operating Income | -181.33M |
| Net Income | -190.42M |
| EBITDA | -190.15M |
| EBIT | - |
| Earnings Per Share (EPS) | -1.83 |
Balance Sheet
The company has $90.12M in cash and $27.43M in debt, giving a net cash position of $62.69M.
| Cash & Cash Equivalents | 90.12M |
| Total Debt | 27.43M |
| Net Cash | 62.69M |
| Retained Earnings | -656.19M |
| Total Assets | 122.53M |
| Working Capital | 121.12M |
Cash Flow
In the last 12 months, operating cash flow was -$124.45M and capital expenditures $0, giving a free cash flow of -$124.45M.
| Operating Cash Flow | -124.45M |
| Capital Expenditures | 0 |
| Free Cash Flow | -124.45M |
| FCF Per Share | -1.2 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
ALVR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -406.67% |
| FCF Yield | -239.31% |
Analyst Forecast
The average price target for ALVR is $1, which is 122.2% higher than the current price. The consensus rating is "Sell".
| Price Target | $1 |
| Price Target Difference | 122.2% |
| Analyst Consensus | Sell |
| Analyst Count | 5 |
Scores
| Altman Z-Score | 13.74 |
| Piotroski F-Score | 4 |